top banner image  

topleft corner image     top right corner image
 


bullet

JACC Homepage JACC Imaging Homepage
Still not a subscriber to JACC Imaging or JACC Interventions?

     top nav image

     

J Am Coll Cardiol Intv, 2009; 2:665-671, doi:10.1016/j.jcin.2009.04.014
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Iida, O.
Right arrow Articles by Nagata, S.
PubMed
Right arrow Articles by Iida, O.
Right arrow Articles by Nagata, S.

Clinical Research

Influence of Stent Fracture on the Long-Term Patency in the Femoro-Popliteal Artery

Experience of 4 Years

Osamu Iida, MD, Shinsuke Nanto, MD, PhD*, Masaaki Uematsu, MD, PhD, Kuniyasu Ikeoka, MD, Shin Okamoto, MD, Seiki Nagata, MD, PhD

Kansai Rosai Hospital, Hyogo, Japan

* Reprint requests and correspondence: Dr. Shinsuke Nanto, Cardiovascular Division, Kansai Rosai Hospital, 3-1-69 Inabaso, Amagasaki 660-8511, Japan (Email: snanto{at}kanrou.net).

Objectives: We investigated the time course of stent patency in the femoro-popliteal artery for as long as 4 years.

Background: Stent fracture has been related to poor 2-year patency in the femoro-popliteal artery.

Methods: We studied 239 consecutive patients who underwent provisional de novo stenting with nitinol stents for 333 limbs (Luminexx stent [C. R. Bard, Inc., Murray Hill, New Jersey] in 91 limbs; Smart stent [Cordis Corp., Miami Lakes, Florida] in 242 limbs) from April 2004 to December 2007. Stent fracture was determined by X-ray with multiple projections. Patency was assessed by duplex ultrasonography as peak systolic velocity ratio <2.4 or by angiography (% diameter stenosis <50%). Primary patency in those with and without stent fracture at follow-up was assessed along with factors influencing stent fracture.

Results: Primary patency was 81%, 74%, 68%, and 65% at 1, 2, 3, and 4 years, respectively. Stent fracture occurred in 14% (78 of 544) per stent and 17% (55 of 333) per limbs. Stent fracture was significantly associated with multiple stent deployments (with fracture = 2.3 ± 0.9 stents vs. without fracture = 1.5 ± 0.7 stents, p < 0.001) and long lesions (with fracture = 208 ± 84 mm vs. without fracture = 121 ± 79 mm, p < 0.001). Primary patency was 68% with fracture versus 83% without fracture at 1 year, p = 0.03; 65% versus 75% at 2 years, p = 0.05; 61% versus 69% at 3 years, p = 0.06; and 61% versus 65% at 4 years, p = 0.07. Neither type 1 nor type 3 fracture affected patency, although type 2 showed the worst patency.

Conclusions: Stent fracture worsened the patency during the first 2 years, but it did not apparently affect patency beyond 2 years. In particular, complete stent separation did not affect patency.

Key Words: endovascular therapy • femoro-popliteal artery • nitinol stent • stent fracture

Abbreviations and Acronyms
  EVT = endovascular therapy
  FPA = femoro-popliteal artery
  SFA = superficial femoral artery
  TASC = TransAtlantic Inter-Society Consensus






 
   
 
home link current link search link archive link topics link cardiology careers link